December 14, 2024 06:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bengaluru techie suicide: Karnataka Police issues summons to wife Nikita, her family members | French President Macron appoints centrist leader Francois Bayrou as new Prime Minister | Congress always prioritised personal interest over Constitution: Rajnath Singh | Jaishankar calls attack on Hindus in Bangladesh 'a source of concern' | Allu Arjun arrested over woman's death in stampede during Pushpa 2 premiere show | RBI receives bomb threat in Russian language, case filed | UP teenager kills mother, lives with body for 5 days | At least six people including a child killed in Tamil Nadu hospital fire | Amid Atul Subhash row, SC says mere harassment is not enough to prove abetment to suicide | India's D Gukesh becomes youngest ever world champion in chess
Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Cipla's generic version of Remdesivir to be cheapest among rivals: Report

Jul 09, 2020, at 05:39 am

Bengaluru/IBNS: Indian drug company Cipla has priced its generic version of Remdesivir, named Cipremi, at Rs 4,000 or USD 53.34 per 100 mg vial, making it the lowest priced versions of the COVID-19 treatment, a Reuters report said.

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Cipla Limited launches generic remdesivir ‘Cipremi’ to fight COVID-19

Jun 22, 2020, at 05:26 pm

New Delhi: Homegrown pharma major Cipla Limited on Monday announced the launch of remdesivir under its brand name Cipremi.